Danish Cancer BioBank

The Danish Cancer Bank (DCB) is a clinical biobank collecting blood and tissue samples from Danish cancer patients, including more than 311,000 samples from over 57,000 individuals. The DCB is the result of a national collaborative initiative that aims to collect biological material across the entire population of Danish cancer patients, yielding data that reflects the full disease pathway for each individual.

Key facts

Name of the connected EIT Health partner: Lasse Boding
Number of individuals: Total 57,360
– 9,695 Blood packages
– 6,849 Tissue packages
– 1,206 Bone marrow packages
Biobank confirmed willingness to provide samples/data for EIT Health studies: Yes
Contact person(s) and contact data
(e-mail address, tel. no) for access purposes:
Estrid Høgdall
Number of samples: Total 311,840
– 13,040 Blood packages
– 10,950 Tissue packages
– 1,337 Bone marrow packages
Sample types: – Blood packages
– Tissue packages
– Bone marrow packages
Website: Danish Cancer Bank

General information

Type of biobank: Clinical
If longitudinal the frequency: Varies
Link to central portal to seek samples and data: Danish Biobank Register
Broad consent: Yes
Option to recall donors: No
Option to recall family members: No

Quality management system:

Link to operational procedures: Nationwide SOPs
Storage: Controlled storage
Compliance with international standards: Aligned with international guidelines
Current ISO certificates: Not available


Clinical data linked to samples: Data on samples such as diagnosis codes and primary organ
Omics data available: Not available
Data standards: Not available
Data security rules: Not available

Biobank related service:

Research support, what type of expertise?: Knowledge about research, guidance on extractions and cohort selection
Core facility services; what type? Link?: Not available
Queries from national health registers: Capacity to perform analysis


IP rules, what is negotiable?: Not available
Requirements to study results (access etc.): Not available
Participant’s right to the information: Not available
Number of access contracts with industry: 2, but many studies where industry is involved